 Dyte | Company operating in Developer Tools. | |
 Dytto | Media & Entertainment company. | |
 E-Pal | E-Pal operates in Gaming. | |
 E-Scape Bio | | |
 E25Bio | | |
 E2B | Enterprise Software company. | San Francisco, CA, US |
 e6data | e6data operates in Data & Analytics. | |
 Eagle | Software that helps civil, structural, and MEP engineers design critical infrastructure at 10x speed. Exists to reenergize the engineering profession. | |
 Earable | Sleep-tracking earbuds. | Boulder, Colorado |
 Earable | Earable is a neurotechnology company developing FRENZ, a brain-sensing wearable that measures neural signals and personalizes sleep support. | |
 Earable, Inc. | | |
 Earendil Robotics | | |
 Earli | Earli’s mission is to make cancer a benign experience by forcing it to reveal and kill itself. | |
 EarliPoint Health | EarliPoint Health is the current brand of EarliTec Diagnostics, a medical device company using eye tracking and software analysis to help clinicians assess autism and associated developmental differences. Its technology originated in research at Children's Healthcare of Atlanta, Emory University and Yale University; the company describes its underlying platform as multimodal AI. EarliPoint Assessment measures visual engagement while a child watches videos. FDA clearance K253442, issued March 5, 2026, covers use as an aid to qualified clinicians assessing children aged 16 through 95 months who are at risk of autism. It is a prescription clinician tool. EarliTec announced its EarliPoint Health rebrand in October 2025. President and CEO Jamie Pagliaro began the role August 1, 2025; scientific founders include Warren Jones and Chief Clinical Officer Ami Klin. The company announced a $19.5 million Series A in February 2022 and a $21.5 million Series B in April 2024. An April 2026 SEC filing reports $3.5 million of debt sold in an ongoing $7 million offering. | |
 Early | Develops home diagnostic devices designed to detect diseases earlier and guide patients toward medical care. | |
 EarlySight | EarlySight develops retinal imaging hardware and AI analysis tools for ophthalmologists, clinical researchers and pharmaceutical companies. Its Cellularis platform combines adaptive optics with transscleral flood illumination to image retinal structures at cellular resolution, including pigment epithelial cells, photoreceptors and the retinal nerve fibre layer. The resulting images support investigation and monitoring of conditions such as age-related macular degeneration, glaucoma and diabetic retinopathy. The EPFL spinout also develops digital biomarker analysis and collaborates with RetinAI to connect its imaging to automated interpretation and longitudinal disease tracking. | |
 EarnBetter | EarnBetter operates in Enterprise Software. | |
 EarnUp | | |
 Earth AI | Earth AI operates in AI. | San Francisco, California |
 Earth AI | | |
 Earth From Another Sun | Earth From Another Sun is an independent game studio developing a science-fiction open-world MMO first-person shooter that combines planetary exploration, large-scale combat, and player-driven progression. | |
 EarthFast | Company operating in Crypto & Web3. | |
 Earthly | Earthly operates in Climate & Energy. | |
 Earthly Technologies | Earthly Technologies operates in Developer Tools. | |
 Earthmover | Earthmover develops cloud data infrastructure for scientific datasets and AI models of the physical world. Its open-source Icechunk engine stores multidimensional tensors and arrays, while Arraylake provides shared catalogs, versioning, permissions and governance for scientific data in customers’ cloud storage. Its compute and delivery services support analysis and access close to the data, and its marketplace connects users with analysis-ready datasets. The platform serves weather, climate, ocean, Earth observation and other scientific workflows, including bioimaging and omics, helping research and commercial teams work with large datasets without building bespoke file-based pipelines. Earthmover is a public benefit corporation founded by climate scientists and open-source developers. | |
 Earthshot Labs | Earthshot is a platform to develop and finance nature-based carbon projects. We bring scientific rigor to carbon markets, support land stewards to get paid for their work, and make nature an investable asset class. | |
 Ease | Ease is a purpose-built benefits administration system making the enrollment experience easy from start to finish. Because benefits matter. | |
 Ease (company) | HR & Talent company. | |
 Easebuzz | Easebuzz operates in Fintech. | |
 EaseCentral | | |
 Easel | Company operating in Developer Tools. | |
 Easemob | Easemob, also known as Huanxin, provides communications-platform software and SDKs that let developers add instant messaging, voice, and customer-service capabilities to mobile and web applications. | |
 Easol | Company operating in SaaS. | |
 Easypost | | |
 Easyrecrue | HR & Talent company. | |
 Eatron Technologies | Company operating in Food & Agriculture. | |
 Ecair | Company operating in Fintech. | |
 Eccocar | Eccocar operates in Mobility & Transportation. | |
 Echelon AI | | |
 Echo Labs | Echo Labs operates in AI. | |
 Echo Neurotechnologies | Echo Neurotechnologies is a San Francisco brain–computer interface company developing hardware and AI systems intended to restore autonomy and communication for people living with neurological disabilities. Its current official recruiting materials describe an early-stage multidisciplinary engineering and AI organisation. UCSF identifies neurosurgeon Edward Chang as a co-founder; published scientific disclosures identify David A. Moses as a director, Kenneth H. Louie as an employee, and Philip Starr as an external consultant. Those research disclosures establish affiliations rather than a complete company roster or regulatory authorisation. In June2026 Intel announced exploratory collaboration with Echo on neuro-AI, speech neuroscience, brain–computer interfaces and neuromorphic/conventional computing architectures. That technology partnership is not treated as an equity investment. A&E Investments’ official portfolio links echo.bio and describes brain–machine interfaces that allow patients to control external devices. Its October2023 partnership entry establishes an investment relationship but does not disclose a financing close, stage or cash amount. No primary-verified priced round or FDA market clearance is asserted. Echo is distinct from Echo Health Ventures, Echo Labs, Echo cloud security and Echo Protocol. | |
 Echodyne | Company operating in Defense & Space. | |
 Echopoint Medical | Echopoint Medical operates in Healthcare. | |
 Eclipse Foods | | |
 Eclore Actuators | Eclore Actuators is a Nantes-based industrial deep-technology company designing and manufacturing polymer components with an automated folding process inspired by origami. Its commercial products include lightweight protective bellows and protection kits for SCARA industrial robots, flat protective bellows and related accessories that shield moving equipment in demanding operating environments. It also develops active polymer components such as actuators, ejectors and grippers, with lifting tubes and level or angle compensators shown as upcoming product ranges. Applications include industrial robotics, defence, aerospace, food production and pharmaceuticals. The company develops its own production and R&D machinery and supplies standard and custom components. | |
 Eclova Therapeutics | Barcelona-based biotechnology company developing next-generation targeted therapeutics at the preclinical stage. Created with the backing of Invivo Partners, the company is currently operating in stealth and has not publicly disclosed its molecular targets, technology platform, disease indications or development candidates. Nicole Clarke leads the company as chief executive, and Invivo partner Laura Rodríguez Gallego chairs its board. | |
 Eclypsium, Inc | Eclypsium’s infrastructure assurance platform protects mission critical hardware and detects compromised devices in enterprises and government agencies. | |
 Eco | Crypto savings network. | San Francisco, California |
 ecobee | Ecobee develops smart thermostats and connected-home devices that help households manage comfort, energy use and security. Its thermostats combine sensors, scheduling and app controls to adjust heating and cooling. | |
 Ecologi | Climate & Energy company. | London, GB |
 Ecomet Logistics | Ecomet Logistics is an Indian multimodal logistics company that combines rail with road freight to make long-haul shipping more efficient and less carbon intensive. It is building a discoverable, standardized operating network for rail-based freight with end-to-end shipment visibility. Its services include door-to-door full-truckload and less-than-truckload transport, station-to-station container rail freight, warehousing and supply-chain consulting. It serves industries including retail, manufacturing, agriculture, pharmaceuticals, energy and construction. | |
 Ecomid | Company operating in E-Commerce & Marketplace. | |
 Ecosmic | | |
 EcoVadis | EcoVadis provides sustainability intelligence for companies and their suppliers. Its ratings assess environmental practices, labour and human rights, ethics and sustainable procurement, producing scorecards and improvement plans that buyers can use in supplier selection and monitoring. Its platform also screens supply-chain risk, gathers carbon-emissions data and supports supplier decarbonisation, combining analyst assessments, documentation and AI-assisted data processing. | |
 Ecovative Design | Uses fungal mycelium to grow materials and food ingredients. Its processes turn biological feedstocks into compostable packaging, foams and textile-like materials, while its AirMycelium platform supports whole-cut mycelium products and production on mushroom farms. Its food spinout MyForest Foods commercializes mycelium-based meat alternatives such as MyBacon. | |
 Edaijia | | |
 Eden Farm | | |
 Edera | Cybersecurity company. | |
 EdgeBit | | |
 EdgeCortix | Japan-based fabless semiconductor company founded in 2019 that develops energy-efficient processors and software for running AI models at the edge. Its hardware and software co-design approach combines reconfigurable AI accelerators with the MERA compiler and software stack. Its SAKURA processors target inference workloads in robotics, industrial automation, defense, aerospace, telecommunications and other connected systems, including generative AI applications. It has engineering and commercial operations in Japan, the United States and India. | |
 Edgee | Company operating in SaaS. | |
 EdgeSpring | | |
 EdgeSpring | EdgeSpring developed enterprise business-intelligence and analytics software that let users explore and act on large operational datasets; Salesforce acquired it in 2013. | |
 Edgeware | Edgeware developed video-delivery infrastructure for broadcasters and telecom operators, including purpose-built servers and content-delivery technology for high-quality television streaming at scale. | |
 Edgybees | Edgybees operates in AI. | |
 Edia | K-12 mathematics practice software. | San Francisco, CA, US |
 Edify | | |
 Edinburgh Molecular Imaging | Develops targeted molecular agents for image-guided cancer detection and therapy. The University of Edinburgh spinout works on fluorescent optical imaging and radiotherapeutic agents based on c-Met targeting. | |
 Edlyft | | |
 Edmodo | Edmodo operates in Education. | |
 Edra | Edra operates in AI. | |
 Educato | Educato operates in Education. | |
 EDURINO | EDURINO operates in Education. | |
 Edyn | | |
 Edyoucated | Education company. | Münster, DE |
 eero | Hardware & Semiconductors company. | |
 Effectiv | Effectiv operates in Healthcare. | |
 Effector Therapeutics | Company operating in Biotech & Life Sciences. | |
 Efference | Builds robotic cameras and integrated computing hardware for high-fidelity perception, synchronized sensor data, teleoperation and AI inference. Its systems support robotics data collection and real-time machine vision. | |
 Efficient Computer | Efficient Computer operates in Hardware & Semiconductors. | |
 Efinix | Efinix develops field-programmable gate arrays and embedded computing solutions for energy-efficient AI and other processing at the edge. Its Quantum programmable architecture underpins Trion and Titanium FPGA families used in machine vision, industrial automation, automotive, communications, medical equipment and physical AI. The company pairs its chips with the Efinity design environment and Sapphire RISC-V system-on-chip solutions so developers can implement custom logic, processor systems and AI acceleration on reconfigurable silicon. | |
 eFishery | | |
 eGenesis | eGenesis develops human-compatible organs from genetically engineered pigs for transplantation. Khosla Ventures is an early investor. | Cambridge, Massachusetts |
 EGIDE | Defense & Space company. | |
 Ego | Ego operates in Consumer. | |
 ego | | |
 Egress | Egress operates in Cybersecurity. | |
 Ehab | Company operating in Construction. | |
 eHealth | | |
 Eholo | Eholo develops subscription software for psychologists and mental health clinics to manage appointments, patient records, informed consent, billing, payments, reminders and video consultations. Its integrated AI tools transcribe sessions and help prepare clinical summaries for professional review, reducing administrative work for practitioners. Co-founders Sonia Torras Garat, a health psychologist, and Eduard Martí Vaquer, an engineer and programmer, created the business during the COVID-19 pandemic. | |
 Eigen Technologies | Company operating in AI. | |
 EigenH AI | EigenH AI builds an AI patient-access and front-desk software platform for independent healthcare practices. Its agents manage patient calls, appointment scheduling and rescheduling, recalls, follow-up and insurance-eligibility preparation within practice-approved rules, escalating urgent, uncertain or clinical questions to staff. The current official site identifies US nephrology groups as its first live specialty. Scheduler, Recaller and Verifier are labeled live; Referrer, Authorizer and Nourisher are labeled beta. Prior-authorization paperwork and nutrition appointment/education workflows remain staff-supervised. Its optional AI Ops services combine human operational teams with AI for revenue cycle, coding, verification, credentialing, scribing, marketing and websites. These are administrative healthcare tools, not established clinical diagnostic or treatment products. The vendor describes scheduling integration through NexHealth. Security and compliance claims are vendor disclosures; its written business-associate agreement and AWS hosting statements are not independent clinical validation or an asserted regulatory product clearance.
Identity reviewed October8,2026: its own company page, privacy policy and August7,2026 terms identify EigenH AI, Inc., a Delaware corporation, with registered corporate office at131 ContinentalDrive,Suite305,Newark,Delaware19713. The office is explicitly corporate identification only, not an operating or support office. Its own linked corporate LinkedIn identifies Austin,Texas as headquarters and founded2026; exact statutory registration identifier and incorporation day are not established in reviewed primary material. The official domain eigenh.ai is directly linked by founder DheerajInampudi on his personal site. Native and read-only SQL aliases/domain checks found no existing company, only a mention within his former employer Circuitry.ai. This company is distinct from Circuitry.ai and no historical employer finance or roles are transferred. Older dental-focused five-agent launch descriptions are time-qualified; current live/beta and nephrology scope follow the official website rather than stale secondary profiles.
Published public-team scope comprises six individually evidenced people: founder DheerajInampudi, founding AI engineer KarthikRommula, founding engineer ShaikMahammadJani, AI automation/voice-workflow engineer BaladityaSaiChinni, cloud engineer BheemaSubramanyeswarReddyTatiparthi, and healthcare product professional HarshaSanamandra. Own individual professional posts and the named engineering-team acknowledgement corroborate the affiliations. Harsha’s exact formal company rank is not published, so the role is scoped to the publicly evidenced team rather than assuming an executive title. Appointment days and a complete private payroll roster are unpublished; the directory’s seven-employee count does not supply a seventh identifiable person. Dheeraj’s authentic personal-site portrait and substantive biography are reused without changing his historical Circuitry engineering role. Authentic new portraits are used only where individually named first-hand assets can be obtained; inaccessible or anonymously labeled directory pictures remain documented gaps, with no guessed image/name associations.
Financing and investments: no primary announcement of an equity/debt financing, investor, grant, valuation, ticket or outbound investment was found in the reviewed official company pages, founder/team disclosures and focused funding searches. This is an evidence gap, not a claim that no private financing exists. No round or investor participation is invented. Its2026 AIBoomi VerticalVelocity/Caravan participation is source-reported founder-market-learning activity, not proof of a paid grant or institutional equity check. Service pricing, customer revenue, platform demonstrations and illustrative operational examples are not investment proceeds. | Austin, Texas, United States (self-published headquarters) · 131 Continental Dr, Suite305, Newark, Delaware19713, UnitedStates (registered corporate identification office; not operating/support office) |
 EigenLayer | EigenLayer operates in AI. | |
 Eight Sleep | Eight Sleep makes a smart mattress cover and sleep system that regulates temperature to improve sleep. Khosla Ventures is an early investor. | New York, New York |
 Eightfold | AI company. | Mountain View, CA, United States |
 Eikon | Biotech & Life Sciences company. | |
 Eikon Therapeutics | Biotech & Life Sciences company. | |
 Einride | Company operating in Logistics & Supply Chain. | |
 Einwert | | |
 Eisen | Fintech company. | New York, US |
 Ejenta | Ejenta develops AI-powered remote healthcare technology based on systems originally used to monitor astronauts. Its platform connects patient data, devices and intelligent agents to help care teams monitor people and support care at home. | |
 Eka Care | Company operating in Healthcare. | |
 Ekho | | |
 Ekho Dealer | | |
 Eko | | |
 Eko Health | AI-enabled digital stethoscope and cardiopulmonary disease detection company. Distinct from Neko Health. | |
 eKuaibao | | |
 Elaborate | Healthcare company. | |
 Elastic | Power insights and outcomes with The Elasticsearch Platform. See into your data and find answers that matter with enterprise solutions designed to help you accelerate time to insight. Try Elastic toda... | |
 Elastifile | | |
 ElastiFlow | Company operating in Data & Analytics. | |
 Elastio | Company operating in Cybersecurity. | |
 Elate | Company operating in SaaS. | |
 Elder | Company operating in Media & Entertainment. | |
 Elea Health | Healthcare company. | |
 Eleanor Health | Healthcare company. | |
 Elecbits | Company operating in Hardware & Semiconductors. | |
 Electric AI | Electric AI operates in Infrastructure & Cloud. | |
 Electric Air | | |
 Electric SQL | | |
 Electric Twin | Electric Twin operates in Robotics & Automation. | |
 Electrified Thermal | Electrified Thermal operates in Climate & Energy. | |
 Electroflow | Electroflow Technologies develops electrochemical processes that extract lithium from low-concentration brines and convert it into lithium iron phosphate cathode material for domestic battery manufacturing. | |
 Electronx | Climate & Energy company. | |
 Elektrofi | Biotech & Life Sciences company. | |
 Elektrofi, Inc. | | |
 Elemeno Health | | |
 Element | Company operating in Cybersecurity. | |
 Element AI | | |
 Element Zero | Company operating in Climate & Energy. | |
 Elemental Machines | Smart lab sensors. | |
 Elementary | | |
 Elementl | Elementl develops Dagster, an open-source data orchestrator for building, observing, and maintaining data pipelines and data assets. | |
 Elementl Power | Elementl Power operates in Developer Tools. | |
 Elementor | | |
 Elementum AI | | |
 Elemind | Develops a wearable headband that measures brain activity and delivers timed acoustic stimulation to help users fall asleep. | |
 Elemy | Pediatric autism and behavioral health at home. | |
 Elephas | | |
 Elephas Biosciences | | |
 Eleplan | Eleplan provides AI-assisted care planning and information sharing for families and teams supporting people with complex health needs. | |
 Elevate Foods | Elevate Foods developed a platform connecting small and medium sized farm-gate food processors in India with regional and international buyers. It worked with existing processors to improve quality management, traceability and market access, helping agricultural produce reach consumers in less perishable forms without building its own factories. Its approach aimed to reduce food loss and improve the commercial opportunities available to small processors. The current 100×100 portfolio lists the investment as terminated; its former website is unavailable. | |
 Elevate K-12 | Education company. | |
 Eleven Labs, Inc. | | |
 Eleven Therapeutics | Company operating in Biotech & Life Sciences. | |
 ElevenLabs | Develops AI models and software for speech and audio. Its products generate expressive synthetic voices, transcribe speech, translate and dub content, and power conversational voice agents. Creators, developers and businesses use its applications and APIs for media production and customer interactions. | London, United Kingdom · New York, New York |
 Elevo | HR & Talent company. | |
 Elfie | Company operating in Fintech. | |
 Eli Lilly and Company | Eli Lilly and Company (NYSE: LLY) is an Indiana-incorporated global biopharmaceutical company founded in 1876 and headquartered at Lilly Corporate Center in Indianapolis. It develops and manufactures medicines across cardiometabolic health, immunology, oncology and neuroscience. Its neuroscience business includes Alzheimer’s disease, migraine and research into neurological disorders, psychiatry and pain. Kisunla (donanemab-azbt) received US FDA approval in July2024 for Alzheimer’s disease, with treatment studied and initiated in the mild cognitive impairment or mild dementia population; that product-specific authorization is not a blanket approval of other investigational medicines or AI systems. Lilly uses AI and data science in drug discovery and offers drug-discovery models through TuneLab. Its Catalyze360 platform comprises the global Lilly Ventures investment arm, Gateway Labs, ExploR&D and TuneLab. Corporate business development separately covers partnering, licensing, direct equity investments, acquisitions and alliance management. The current published roster includes its global board and executive committee plus named corporate-partnering and innovation-program contacts. David Ricks is chair and CEO; Carole Ho leads Lilly Neuroscience, Daniel Skovronsky leads research and product development, and Jacob Van Naarden leads oncology and corporate business development. This profile is the legal corporate parent; the distinct Lilly Asia Ventures manager and other legacy Lilly-named investment records are preserved separately. Borrowing proceeds, commercial collaborations, research partnerships, manufacturing commitments and market value are distinct financial concepts; prospective milestones or credit limits are not treated as completed investment checks. | Indianapolis, Indiana, United States |
 Elice | Elice develops AI infrastructure, enterprise AI software and practical technology education platforms. Its Elice Cloud business provides GPU computing, virtualization infrastructure, development environments, model deployment and portable modular AI data centers. Its Helpy software helps organizations analyze documents, structure internal knowledge, use generative AI and deploy coding agents, while Elice LXP and Elice Test support hands-on learning and skills assessment. Based in Seoul and founded in 2015, Elice serves enterprises, public institutions, schools and researchers. | |
 Elicit | AI research assistant that automates literature review and reasoning for scientists. Spinout of Ought. | Oakland, California |
 Eligo Bioscience | Company operating in Biotech & Life Sciences. | |
 Elio | Company operating in Enterprise Software. | |
 Elion | Elion operates in Climate & Energy. | |
 Eliq | Energy data platform for utilities combining customer insights and operational intelligence to improve service, reduce churn and grow revenue. | |
 Elixir Pharmaceuticals | | |
 Eliyan | Eliyan operates in Hardware & Semiconductors. | |
 Elkedonia | Elkedonia is a Franco-Belgian biotechnology company launched in 2025, headquartered in Strasbourg with an affiliate in Charleroi. Built by Argobio from research led by Jocelyne Caboche at Sorbonne University, it develops small-molecule inhibitors of the intracellular ELK1 protein for treatment-resistant depression and other neuropsychiatric disorders. Its preclinical neuroplastogen program aims to restore neuroplasticity through a non-synaptic mechanism. Biomarker research and AI support its precision-medicine strategy for patient selection and development. | |
 Ellevest | Company operating in Fintech. | |
 Ellipsis | | |
 Ellipsis Health | Company operating in Healthcare. | |
 Ellipsis Health, Inc. | Ellipsis Health develops voice-based artificial intelligence that analyzes natural speech to screen for and monitor behavioral-health conditions and support clinical care workflows. | |
 Ellipsus | Company operating in Enterprise Software. | |
 Elliptic | Elliptic operates in Crypto & Web3. | |
 Ello | | |
 ElMindA | | |
 Elo Life | Food & Agriculture company. | |
 Eloquent AI | | |
 ELOQUII | Plus-size fashion retailer. | |
 Elpha | | |
 Elpha Secure | | |
 Elphinstone, Inc. | | |
 Elroy Air | Elroy Air operates in Logistics & Supply Chain. | |
 Elsa | Education company. | |
 Elucd | | |
 Elucidate | Data & Analytics company. | |
 Elyos | Elyos builds AI agents for field-service businesses, automating customer calls and operational workflows while integrating with the systems contractors use to schedule and manage jobs. | |
 ELYOS AI | AI software company serving trades and field-service businesses with agents for telephone calls, job bookings and appointment confirmation. | |
 Elyos Energy | Elyos Energy, now Elyos, provides software for commercial buildings and service businesses, originally helping operators monitor and shift energy use and later expanding into AI agents for field-service workflows. | |
 Elysium Health | Healthcare company. | |
 Emalex | | |
 Emalex Biosciences | | |
 Embark | AI company. | Boston, Massachusetts |
 Embark Trucks | Robotics & Automation company. | |
 Embat | Fintech company. | |
 Embed | Payments built for vertical SaaS platforms | Netherlands |
 Embeddable | Embeddable develops infrastructure for adding customer-facing analytics to SaaS applications. Developers define data models, access rules, chart components and themes in code; product teams and customers assemble governed dashboards with a no-code builder. Its native web components embed reports without iframes, while the backend manages query performance, caching, tenant permissions and a shared semantic layer. The platform also supports self-service reporting and AI-assisted analytics authoring, with permissions and approved metrics enforced beneath the interface. Embeddable is operated by the UK company TMD Technology Limited. | |
 ember | Company operating in Consumer. | |
 Ember | | |
 Ember Software | Ember Software operates in SaaS. | |
 Embla | Danish weight-loss and metabolic health company. | Denmark |
 Embodied | Embodied developed socially assistive robots intended to support wellbeing and child development. Its Moxie companion robot used conversation and interactive activities to help children practice social and emotional skills. | |
 Embodied AI | Embodied AI is a Lausanne robotics company with a team in Rome. It combines soft robotic hardware, teleoperation and task-specific AI models that learn from work on production lines. Its systems target manufacturing and logistics tasks such as electronics assembly, kitting and cable handling, with remote operator intervention supporting continuous learning. The company integrates its hardware, data collection and model-training platform. | |
 Embrace | Healthcare company. | |
 Embrace | | |
 Embrane | Embrane developed application-centric network-services software for data centers, providing virtualized firewalls, VPNs, load balancers, and related services before its acquisition by Cisco in 2015. | |
 Embucket | | |
 Emburse | | |
 Emerald AI | Emerald AI develops software that coordinates AI workloads and data-center power consumption so computing facilities can respond to electricity-grid constraints while maintaining workload performance. Its Conductor platform turns AI data centers into flexible grid assets, helping utilities connect additional demand and manage peaks rather than relying solely on new generation or transmission. Founded in November 2024, the company works with utilities, AI companies and data-center operators, and has progressed from international demonstrations to commercial deployment at multi-megawatt scale. Its work combines AI systems engineering, power-grid optimization and energy policy. | |
 Emerge Career | | |
 Emerge Tools | | |
 Emergent Labs Inc | Company operating in AI. | |
 Emergent Payments | Transform ideas into production-ready web and mobile apps with vibe coding. Emergent's AI agents build in minutes through conversation, no code. | |
 Emi | Company operating in Consumer. | |
 Emi Labs | Company operating in Consumer. | |
 Emidat | Data & Analytics company. | |
 Emidat | | |
 Emm | Emm operates in Healthcare. | |
 EMMA | EMMA operates in Fintech. | |
 Emmi AI | Company operating in AI. | |
 Emobi | | |
 EmpathMSP | Provides training, onboarding and team-development software for managed service providers. Its platform combines role-specific learning, repeatable onboarding processes and accountability tools to help MSPs develop staff and improve service, sales and customer-management operations. The company describes itself as self-funded. | |
 Empathy | Healthcare company. | New York, NY, US |
 Empatica | Empatica develops AI-enabled medical wearables, physiological sensing, connected-health software and digital biomarkers for remote monitoring, clinical trials and research. Its neurological applications span epilepsy, Parkinson’s and movement disorders, sleep and actigraphy. Current products combine EmbracePlus and EmbraceMini wearables with the Care software suite and research APIs; E4 and Embrace2 are discontinued hardware. The company is co-founded by CEO Matteo Lai and Chief Scientist Rosalind Picard.
Its public directory names five operating leaders and seven external medical/scientific supporters. The September2026 summit separately identifies scientific adviser Larsson Omberg. External supporters are distinguished from employees and statutory directors. Dated historical board and regulatory affiliations are retained separately; Marisa Cruz’s2022 CMO role is former. The privately reported100-plus employee headcount does not provide an individually published staff roster. Genuine own portraits cover the current named directory, with existing shared photographs preserved and unavailable historical portraits left explicit.
The business operates through US Empatica Inc. inCambridge,Massachusetts and Italian regulated manufacturer Empatica Srl inMilan, VAT IT07462810966. Primary SEC CIK1606818 identifies the original US legal name Physiio International,Inc., formed2013, and the same issuer’s later EmpaticaInc. name. The2013 founding year refers to that US legal entity, without inventing dates for earlier research projects or unrelated namesakes.
EpiMonitor’s FDA510(k) clearances K232915 and K250515 cover prescription adjunct monitoring of patterns associated with generalized tonic-clonic seizures, including patients aged6andolder, with caregiver alerts. It does not prevent seizures, diagnose every seizure type or guarantee detection. The physiological HealthMonitoringPlatform has separate clearance K242737. FDAK260374, decidedAugust14,2026 and announcedAugust19, covers Parkinson’s movement monitoring for individuals aged46to83: tremor, bradykinesia and dyskinesia quantification, medication reminders and sleep-associated activity. These are defined monitoring clearances, not unrestricted diagnostic or therapeutic approvals.
Empatica acquired PKGHealth in2025, reported in its October1 own post, strengthening Parkinson’s algorithms and digital endpoints. The purchase consideration and precise acquired legal entity remain unpublished in the reviewed announcement. PKGHealth’s relationship to GlobalKineticsCorporation requires a separate legal-identity audit before investment records are attributed.
A primary2014 FormD reports USD1,000,000 actually sold from a USD2,000,000 offering, with first saleApril17; exact final closing day is unpublished. The existing2016 USD5M/December1 financing and AllenTaylor personal investment are preserved. InvitaliaVenturesSGR’s own retrospective confirms completed Oct–Dec2016 SeriesA backing through ItaliaVentureI; the same legal manager was renamed CDPVentureCapitalSGR inJanuary2020. That primary statement does not independently establish the old personal-source amount or exact day.
EndeavorCatalyst’s own retrospective separately confirms an Empatica investment in2017, with stage, day, ticket and priced-round allocation unpublished. OrigineSGR’s current portfolio dates historical InnogestSGR backing toQ4,2016 and reports a14.3% stake. Origine is the same legal manager renamed inOctober2025. These qualified backing relationships may overlap previously documented financing; their unknown amounts are not treated as additional cash raises, and ownership percentages are not investment tickets.
The issuer announced its closed SeriesB onNovember22,2022, co-led by SanofiVentures and RA CapitalManagement with BlackOpalVentures participating; final round size was undisclosed. An earlier2022 SEC offering reported USD25,949,980 sold-to-date against USD33,949,997 offered, with first saleJuly21. That snapshot is qualified alongside the financing rather than duplicated as a separate August cash event or asserted as the final November total. Individual institutional tickets and subscribing funds remain unpublished.
BARDA/DRIVe2019–2020 materials describe respiratory-infection research collaboration without establishing an exact actual award or disbursement in the reviewed sources. The2024 PROJECTREMOTE statement identifies Allucent as the BARDA award recipient and Empatica as a technology partner; the programme’s funding is not attributed to Empatica as equity or a company grant. | |
 Emporix | Emporix operates in E-Commerce & Marketplace. | |
 Empower | | |
 Emulate | Organ-on-a-Chip. Founders Fund led $36M Series C (2018). | Boston, Massachusetts |
 Emversity | Emversity embeds industry-aligned education, practical training and placement support in universities, with programs focused on sectors including healthcare and hospitality. | |
 Enable | Rebate management for manufacturers, distributors, and retailers. Founded 2017. San Francisco. | San Francisco, California |
 Enable Medicine | Biotech & Life Sciences company. | |
 Enable Us | | |
 enaDyne | enaDyne operates in Climate & Energy. | |
 ENAPI | Company operating in Climate & Energy. | |
 Enara Health | Enara Health operates a technology-enabled weight management program combining personalized medical care, nutrition support and behavioral coaching. | |
 EnCharge AI | Develops energy-efficient AI chips and computing systems based on analog in-memory computation, targeting AI inference in edge devices and other power-constrained applications. | |
 Enclave | Enclave operates in Cybersecurity. | |
 Encoded Therapeutics | | |
 Encodia | | |
 Encord | Infrastructure & Cloud company. | |
 Encore | Media & Entertainment company. | |
 Encuadrado | | |
 End Game | Company operating in Cybersecurity. | |
 Endear Health | Endear Health operates in Healthcare. | |
 Endel | Endel creates personalized soundscapes designed to support focus, relaxation and sleep. Its apps generate adaptive audio using algorithms and contextual signals such as time of day and user activity. | |
 Ender | PropTech company. | |
 EndLyz Therapeutics | EndLyz Therapeutics develops small-molecule modulators of ATP13A2 and ATP10B lysosomal transporters for Parkinson's disease and other neurodegenerative disorders. Founded in2021 by SV Health Investors' Dementia Discovery Fund, the company aims to restore endo-lysosomal function; its initial development focus includes genetic Parkinson's subsets. Its March31,2025 launch announced an exclusive collaboration with KU Leuven researcher and scientific co-founder Peter Vangheluwe, with Quantum AI supporting drug-discovery research. Research goals and planned IND-enabling studies are not claims of clinical efficacy or regulatory approval. The current public directory names six scientific/operating leaders and five board affiliations across ten unique people, led by CEO and co-founder Joanna Wolak. US SEC filings identify Endlyz Therapeutics Inc., Delaware, CIK1875514. The July2021 filing reported USD3.25M equity sold toward a USD6.5M offering; this is an interim snapshot, not proof of final capital. The May2026 filing for a distinct March2026 offering reports USD17,250,395 sold, explicitly including conversions of earlier securities, so new cash cannot be equated to that total. The issuer describes Seed2 financing in2026 without a separately verified cash amount here. March2025 issuer disclosures identify USD2.2M MichaelJFoxFoundation programme funding; paid-to-date and instrument details remain unverified. Published backers include DDF, OxfordScienceEnterprises, AbbVieVentures, Parkinson'sUK and KU Leuven CD3; publication alone does not allocate them to a specific priced event. Current employee completeness and all private investor allocations remain unverified. | |
 Endor Labs | Company operating in Cybersecurity. | |
 Endowus | | |
 Endpoint Health | | |
 Endurance Energy | Seafloor geothermal power. Founders Fund led $54M Series A in June 2026. | Seattle, Washington |
 EnduroSat | Satellite manufacturer; €43M investment led by Founders Fund (May 2025). | Sofia, Bulgaria |
 Enevo | Logistics & Supply Chain company. | |
 Enfabrica | Company operating in Hardware & Semiconductors. | |
 EnFi | Company operating in Fintech. | |
 Enfusion | Company operating in Fintech. | |
 Engageli | Engageli operates in Education. | |
 Engagesoft | Company operating in Enterprise Software. | |
 Engagor | Company operating in Marketing & Advertising. | |
 Engine | Company operating in Enterprise Software. | |
 Engine Biosciences | Engine Biosciences is a Singapore and Silicon Valley biotechnology company applying machine learning and experimental genetics to discover precision oncology medicines and patient-selection biomarkers. Its NetMAPPR network-biology platform combines computational analysis with data from the CombiGEM combinatorial CRISPR system, enabling experimental tests of predicted genetic interactions. The work includes synthetic-lethal cancer targets and preclinical therapeutic programmes; these are research and development activities, not approved cancer treatments. The website’s legal notice identifies Engine Biosciences Pte Ltd and its affiliate Engine Biosciences Inc. Investor EDBI’s contemporaneous 2018 announcement dates the business’s founding to2015. The current October2026 homepage remains active but no longer publishes the team or programme directory. The latest recovered original directory, archived April16,2026, names20 people across management, board, board observers and scientific advisers. It identifies co-founder Jeffrey Lu as CEO, Robert Abraham as CSO and Yaron Turpaz as CIO; their roles are last confirmed in that directory rather than assumed from a withdrawn current roster. Historical co-founder Daphne Teo is separately documented in the2018 announcement. David M. Epstein’s archived interim R&D role is marked historical because the company subsequently announced his death. Scientific founders and advisers include Timothy Lu, James Collins, Prashant Mali, Hu Li and Martin Kampmann. Three independently documented completed financings are retained: USD10M seed January31,2018; USD43M SeriesA May26,2021; and an additional USD27M SeriesA extension October31,2023. The2023 issuer reports USD70M total SeriesA and USD86M cumulative financing; neither aggregate is an extra round, and an unexplained difference from individually announced rounds is not inferred as cash. Secondary2026 financing reports remain pending primary filing or issuer verification. | |
 Engine Labs | Company operating in Media & Entertainment. | |
 Engine Yard | Engine Yard operates in Infrastructure & Cloud. | |
 Engrail Therapeutics | Engrail Therapeutics is a San Diego-based clinical-stage neuroscience pharmaceutical company founded in 2019. It develops precision-targeted medicines for neuropsychiatric and neurodevelopmental disorders using acquisition, licensing, internal research and clinical development. Its published pipeline includes ENX-102, a selective GABAA modulator for anxiety; ENX-104, targeting dopamine D2/D3 autoreceptors for depression with anhedonia; ENX-205, targeting serotonin and dopamine receptors for PTSD and mood disorders; and ENX-203 (elesclomol), a copper ionophore being developed for Menkes disease. These programs remain investigational. Vikram Sudarsan is president and CEO, Kimberly Vanover is CSO and Paul Cayer is CFO. The company raised an initial USD32 million Series A in June 2020, extended by USD32 million in August 2021 to USD64 million total. A March 2024 USD157 million Series B, co-led by F-Prime Capital, Forbion and Norwest, was extended by USD10 million from Foresite Capital in August 2024, bringing that same round to USD167 million. | |
 Engram | Engram operates in AI. | |
 Engram Lab | Engram develops contextual and memory models that give enterprise AI agents persistent, evolving knowledge about users and workflows. | |
 Engrate | Company operating in Climate & Energy. | |
 Enhanced Radar | | |
 Enigma | Enigma developed privacy-preserving computation technology for decentralized applications; its work helped lead to the Secret Network ecosystem. | |
 Enjamb Labs | | |
 Enjoy Technology, Inc. | | |
 EnjoyHQ | EnjoyHQ (formerly NomNom Insights) provides a centralized hub for qualitative and quantitative research, enabling faster synthesis, tagging, and collaboration across teams. The company was acquired by UserZoom in 2021 and today operates within UserTesting. | 🇬🇧 · UK |
 Enlaza | Enlaza Therapeutics develops covalent biologic medicines using its War-Lock platform to create targeted therapies with durable binding. | |
 Enlaza Therapeutics | | |
 Enlife Research | Develops AI-assisted blood biomarker diagnostics for early detection and risk assessment of neurodegenerative diseases, including Alzheimer’s. Its research combines nanoscale sensing, blood-based biomarkers and machine learning to make screening more accessible; the diagnostic platform is undergoing development and clinical validation. | |
 Enlightra | | |
 Enode | Enode operates in Climate & Energy. | |
 ENODIA THERAPEUTICS | Biotech & Life Sciences company. | |
 Enpal | Company operating in Climate & Energy. | |
 EnPlusOne Bio | Develops enzymatic technology for manufacturing RNA medicines. Its ezRNA platform uses engineered enzymes to synthesize RNA, including chemically modified sequences, to support drug discovery and scalable production of therapeutic oligonucleotides. | |
 EnPowered | | |
 Enriched Ag | Monitoring Agriculture at Scale Conservation & Soil Health Forage Production Invasives Animal Health – Wellbeing Infrastructure Hazards Profitability & Sustainability […] | |
 enSilo | | |
 Enso | Healthcare company. | |
 Enso Vascular | Medical-technology company developing a topical patch for vascular-access site preparation before needle insertion. The formulation combines local anesthetic delivery and vessel conditioning, with potential applications in neurovascular and cardiac catheterization. Its lead program remains in development toward an initial human pilot study. | New York, New York, US |
 EnsoData | EnsoData is a Madison, Wisconsin healthcare AI company founded in 2015 that analyzes physiological waveform data for sleep medicine. EnsoSleep provides clinician-reviewed scoring of polysomnography and home sleep tests, including EEG-based sleep staging. EnsoHST supports multi-night home sleep testing from pulse-oximetry signals, while EnsoHub provides a unified workflow for reviewing studies and reports. The company's current product ecosystem also includes Therapy Track for longer-term monitoring. EEG-based sleep analysis and peripheral photoplethysmography are different signal modalities. EnsoSleep's FDA clearance K210034 covers specified adult sleep studies and in-lab polysomnography for patients aged 13 and older, with automatically scored results subject to clinician verification. Aurora, subsequently marketed as EnsoSleep PPG, received FDA clearance K231355 for adult pulse-oximetry sleep analysis. Current leadership includes President and CEO Justin Mortara, cofounder and Executive Chairman Chris Fernandez, Chief AI Officer Sam Rusk and CTO Nick Glattard. EnsoData announced a $9 million Series A in 2020, a separate $20 million Series A extension in 2022 and a $20 million Series B in 2025. CIBC disclosed a growth-capital credit facility in May 2026 without specifying its size. | |
 Enspire DBS Therapy | Enspire DBS Therapy, Inc. is a Cleveland, Ohio medical-device company developing deep brain stimulation combined with structured rehabilitation for people with chronic upper-extremity impairment after stroke. Cleveland Clinic describes it as a spinout established in2010 to commercialize research by André Machado and Kenneth Baker. Its investigational approach stimulates cerebellar pathways to support rehabilitation and motor recovery. The company sponsors RESTORE, a multicenter pivotal PhaseII/III study, following the small EDEN feasibility study. The device is investigational and limited by United States law to investigational use; clinical studies and preclinical findings do not establish marketing approval or proven benefit for all patients. A January2026 SeriesB1 financing supports continued pivotal-trial enrollment. Publicly identifiable personnel include company staff, directors, scientific researchers and qualified historical advisors; a complete current employee directory is not published. | |
 Enter | Brazilian legal AI (EnterOS). Founders Fund co-led Series A with Sequoia. | São Paulo, Brazil |
 Enter | Brazilian legal AI (EnterOS). Founders Fund co-led Series A with Sequoia. | São Paulo, Brazil |
 Enterpret | Company operating in Data & Analytics. | |
 Enterprise Bot | Conversational AI software company providing enterprise chatbots, voice and email assistants, agent support and workflow automation. Its platform serves contact centers and internal support teams, including financial services, insurance, transport and healthcare, with integrations into existing business systems. | |
 Enterprise Therapeutics | Develops small molecule medicines for respiratory diseases, including cystic fibrosis. Its ion-channel therapies aim to hydrate airway mucus and improve clearance; inhaled ENaC blocker ETD001 is in clinical development. | |
 EntheogeniX | EntheogeniX is an atai Life Sciences drug-discovery company using AI-enabled computational biophysics to identify next-generation mental-health drug candidates. | |
 Entire | Entire operates in Enterprise Software. | |
 Entrepreneur First | Company operating in HR & Talent. | |
 Entropik | Entropik operates in Marketing & Advertising. | |
 Entropy | | |
 Enttor | Enttor operates in Marketing & Advertising. | |
 Entvin | | |
 Enumerix | | |
 Enveda Biosciences | Company operating in Healthcare. | |
 enVerid | | |
 enVerid Systems | | |
 Enviria | Company operating in Climate & Energy. | |
 Envision Group | | |
 Envoy | Envoy operates in Enterprise Software. | |
 Enzai | Company operating in AI. | |
 Enzo Health | Healthcare company. | |
 Enzymit | Company operating in Biotech & Life Sciences. | |
 Eolas Medical | Healthcare platform organising the world's medical information | UK |
 Eon | Cloud backup posture management that turns backups into a living, searchable asset. Launched out of stealth in 2024. | New York, New York |
 EON | | |
 EON Dental | Company operating in Healthcare. | |
 Eonite Perception | Eonite Perception developed low-latency 3D mapping, reconstruction and inside-out positional-tracking software for AR/VR, robotics and autonomous systems; Intel acquired it for integration with Mobileye in 2019. | |
 Epana Bio | Develops precision therapies for autoimmune diseases by targeting the cells responsible for dysfunctional immune responses. It applies genomics and AI to disease biology and therapeutic design, aiming to reset immune function rather than only manage symptoms. | |
 EpiBiologics | EpiBiologics develops bispecific antibodies that selectively remove disease-causing membrane and extracellular proteins. Its EpiTAC platform recruits tissue-specific cell-surface receptors to degrade targets while sparing healthy tissue, with therapeutic programs in oncology and immunology and potential applications in neurological disease. Lead candidate EPI-326 is an investigational EGFR degrader in a Phase 1 solid-tumor study. The company was co-incubated by Mubadala Capital and Polaris Partners from scientific founder Jim Wells’s UCSF research. | |
 Epic Games | Video-game and interactive entertainment technology company, creator of Unreal Engine. Corporate investment activity is distinct from being a venture capital fund. | |
 Epic Games | Company operating in Gaming. | |
 Epicbrief | Legal company. | |
 Epicrispr Biotechnologies | Epigenetic neuromuscular therapy (EPI-321 for FSHD). | |
 Epidemic Sound | Media & Entertainment company. | |
 Epifi | | |
 Epiminds | Marketing & Advertising company. | |
 Epinote | Company operating in SaaS. | |
 Epiome | AI biotechnology company developing a computational brain-discovery platform for neurological drug research. It uses blood-sample data to infer cell-specific molecular and epigenetic features of the brain, aiming to identify biomarkers, disease mechanisms and drug targets without directly sampling brain tissue. Starting with Alzheimer’s disease, Epiome seeks to help pharmaceutical researchers stratify clinical trials and develop treatments that slow or prevent neurodegeneration. It combines machine learning with functional genomics and cell biology, pursuing both discovery services for pharmaceutical partners and an internal therapeutic pipeline. Its published founders are Rowan Rimington and Jessie Li. | |
 Epirium Bio | | |
 Epirium Bio | | |
 Epirus | Epirus operates in Defense & Space. | |
 Epitel | Wireless wearable EEG company. REMI sensors plus Vigilenz AI for seizure detection in hospital and at-home/ambulatory settings. Founded by Mark Lehmkuhle (now CTO); Steve Pacelli (former Dexcom) is CEO. Less similar to wearable EEG semantic decoding: this is seizure monitoring and hospital/home workflow, not language decoding. | Salt Lake City, Utah |
 Epoch | The most trusted first-mile data provider for supply chains. One API for EUDR compliance, carbon reporting, water stress, and biodiversity — powering platforms, corporates, and suppliers. | |
 Epoxy | | |
 Eppo | Eppo operates in Data & Analytics. | |
 Epsagon | | |
 Epsagon | | |
 Epsilogen | Develops antibody therapies for cancer using IgE, IgA and IgG antibody formats. Its lead MOv18 IgE program targets folate receptor alpha and is being studied in ovarian cancer. | |
 Epsilon3 | Company operating in Enterprise Software. | |
 EQON | EQON develops electronic controllers and cloud software that reduce wasted electricity in heating cables. Its patented dimming technology replaces simple on/off switching with precise, real-time power regulation, so industrial and infrastructure heating systems receive the heat they need. The TC32 controller connects to the heating-cable supply, while EQON Online uses inputs such as weather forecasts, sensors and machine-learned algorithms to monitor energy consumption and equipment condition. Applications include industrial process temperatures, frost protection on ships and offshore equipment, snow and ice melting in cities, and railway infrastructure. TC32 IoT supports a subscription service for buildings and land-based systems; TC32 Industrial supports more demanding environments and integration with SCADA control systems. EQON publishes deployments with municipalities, Nordic Pharma and offshore operator COSL, and distributes its technology through electrical installers and wholesale partners. Founded in 2018 and based in Stavanger, the Norwegian business is legally EQON AS, organization number 920882935, formerly SAFE ARCTIC AS. | Stavanger, Norway |
 EQRx | EQRx operates in Biotech & Life Sciences. | |
 Equals | Equals operates in Data & Analytics. | |
 EquiLibre | Fintech company. | |
 EquiLibre | | |
 Equilibrium Energy | Energy company. | |
 Equip | Healthcare company. | San Diego, California |
 Equipment Share | | |
 ERA | ERA operates in PropTech. | |
 Erad | | |
 EraDrive | EraDrive delivers compact, AI-powered self-driving modules that bring autonomy to any spacecraft, enabling onboard navigation, control, collision avoidance, and visual awareness in orbit. | 🇺🇸 · USA |
 Erasca | Erasca operates in Biotech & Life Sciences. | |
 Erebor | Erebor operates in Enterprise Software. | Columbus, Ohio |
 Erebor | | |
 Erebor | Erebor is a proposed U.S. digital bank focused on technology companies, startups, and digital-asset businesses. | |
 Erebor Bank | | |
 Eridu | Builds networking chips and systems designed to connect accelerators in large AI data centers. | |
 Eruditus | Eruditus operates in Education. | |
 Escape | | |
 Escher Reality | AR cloud company acquired by Niantic. | |
 Escient Pharmaceuticals | Company operating in Biotech & Life Sciences. | |
 Esmito | Provides battery swapping technology and infrastructure for electric two-wheelers and three-wheelers. | |
 Esper | Esper operates in Enterprise Software. | Bellevue, WA, United States |
 Espressive | | |
 Espresso Systems | Espresso Systems operates in Crypto & Web3. | |
 Essential Products | Essential Products was a consumer-electronics company founded by Android co-creator Andy Rubin. It developed the Essential Phone and explored connected-home products and new mobile-device designs before ceasing operations. | |
 Essor | | |
 Esteam | Developed AI and speech-recognition tools for assessing children’s reading skills and supporting literacy instruction. Ignite Reading acquired the company in 2025. | |
 eSteps Health | eSteps Health develops smart insoles, a mobile app and a clinician dashboard for monitoring gait and mobility between visits. Its platform combines movement sensors and AI analysis to support rehabilitation and mobility assessment, including applications for neurological movement disorders. Founded from University of Bologna biomechanics research in 2020, it moved its base to Boston in 2022 while retaining research and engineering in Italy. | |
 Estes | Climate & Energy company. | |
 Estimote | Estimote operates in Hardware & Semiconductors. | |
 Estoca | | |
 Etched | Company operating in Hardware & Semiconductors. | |
 Eternal | Company listed on Goldi Founders Fund portfolio. | |
 Eterneva | Consumer company. | Kerrville, Texas, United States |
 Ethena | SaaS company. | |
 EtherealX | Builds reusable orbital launch vehicles designed to return both rocket stages, lowering the cost of carrying satellites and other payloads into space. | |
 Ethereum | Ethereum is an open-source blockchain platform for programmable smart contracts and decentralized applications. | |
 Etherfuse | Company operating in Crypto & Web3. | |
 etherWhere | etherWhere operates in Hardware & Semiconductors. | |
 Ethic | Sustainable wealth-management platform that builds customized values-aligned portfolios. | New York, New York |
 Ethon AI | AI company. | |
 EthonAI | | |
 Ethos | Ethos operates in Insurance. | |
 Ethos Life | Ethos Life is a digital life-insurance company that uses technology and predictive analytics to simplify underwriting and enable online applications. | |
 Ethos Wallet | | |
 EthosX | | |
 Etleap | Etleap operates in Infrastructure & Cloud. | |
 Etsy | Etsy operates in E-Commerce & Marketplace. | |
 Eudia | Legal company. | |
 Euler Motors | Euler Motors operates in Mobility & Transportation. | |
 Eureka Health | Company operating in Healthcare. | |
 Eureka Network AISBL | Eureka Network AISBL is the Belgian international nonprofit association operating the intergovernmental Eureka research and innovation network. Its enterprise number is BE 0429.585.680 and registered office is Avenue de Tervueren 2, 1040 Etterbeek, Brussels. The international initiative began on 17 July 1985; the legal association acquired personality on 21 October 1986. Authentic French notarised statutes and the Belgian KBO register establish continuity from association d'EUREKA to Eureka Network, its current registered name since 6 September 2024. The Secretariat is part of this institution, distinct from unrelated Eureka venture managers and technology companies.
The network supports international advanced-technology research and commercialisation by companies, universities and research organisations across 47 countries. Programmes include Eurostars, Innowwide, Eureka Clusters, Network Projects, Globalstars and Investment Readiness. Its AI and life-science relevance includes gMendel's genetic diagnostics project, which the company's 2023 review identifies as Innowwide-supported and completed in November 2023. A Eureka project association alone does not prove that this institution paid every national research grant or bought equity.
Innowwide is an EU-funded market-feasibility grant programme administered by Eureka within the European Partnership on Innovative SMEs, rather than a separate company, LP fund or additional cash buyer. Latvia's original September 2022 government publication identifies Association d'Eureka AISBL as coordinator under European Commission grant agreement 101055476, signed on 20 June 2022. Standard support is up to EUR 60,000 for a six-month SME project, with an independent local subcontractor. Programme ceilings and consultant-reported awards remain distinct from actual paid-to-date cash and payment dates. The earlier Horizon 2020 pilot/CDTI consortium is not automatically the provider for a 2022 first-call award. Innovation Fund Denmark explicitly states it does not award Innowwide funding, so the programme is not duplicated as its national Eurostars contribution.
The current Secretariat directory names eight managers. Its approximate 40 employees are not inferred as a full named roster. The sixteen published Belgian Chair 2026–27 people are separately scoped external representatives or support from BELSPO, Innoviris, VLAIO and SPW EER. Belgium's chair runs from 1 July 2026 to 30 June 2027, with Aziz Naji as published President. Former Swiss President Marc Pauchard is not represented as current President, although the October 2026 KBO register separately retains his statutory directorship. Brit Helle's daily-management appointment is 1 September 2021; migrated 2025 news timestamps are not appointment dates.
The direct legal register supplies nine statutory directors. Differences between registry names Urs Gut, Rudolf Grasveld, Kyeong Je and Agnieszka Ratjczak and published board names Andreas Gut, Dolf Grasveld, Yeon Woo Choi and Agnieszka Ratajczak remain qualified without unsupported person merges. The official logo and 24 named current Secretariat/Belgian Chair portraits were visually verified. Eight statutory-only people have unresolved authentic-portrait and expanded-biography gaps. EU co-funding, membership contributions, grant envelopes and network-wide investment totals are institutional resources, rather than AUM, LP fund closes or newly paid company rounds. | Avenue de Tervueren 2, 1040 Etterbeek, Brussels, Belgium |
 European Innovation Council and SMEs Executive Agency (EISMEA) | EISMEA is the European Innovation Council and SMEs Executive Agency, established April1,2021 to implement EU innovation and small-business programmes. It administers activities including EIC Pathfinder, Transition, Accelerator and business acceleration services, innovation ecosystems, Single Market SME programmes and consumer programmes, supporting fields that include artificial intelligence, deep technology and health innovation. It is a European Commission executive agency and granting authority, distinct from the EIC Fund’s equity investment vehicle, EIB, EIF and private venture-capital managers. The current official organisation chart is effective October1,2026 and publicly identifies fifty leadership, management, deputy, policy-assistant and administrative-team affiliations, led by Director Momchil Sabev. The chart date is not asserted as the personal appointment date for each individual; the private employee roster is not inferred. Its official website uses European Commission institutional branding, faithfully retained as published shared agency branding rather than an invented independent logo. Public programme budgets, awarded grants and signed EU contribution ceilings do not prove paid investment cash or closed LP funds. Aindo explicitly names EISMEA as authority for its SydAi grant; CORDIS records agreement101218531 with signatureJune20,2025 and EU contribution EUR2,080,085.71. That is a grant contribution amount, not a proven cash disbursement, and the beneficiary issuer owns the funding event and institutional relationship. Original organisation-chart portrait objects are archived; person-to-image binding verification remains in progress before additional portraits are assigned. | |
 ev.energy | Climate & Energy company. | |
 Evariant | | |
 Evaro | Evaro operates in Consumer. | |
 Eve | Eve operates in Mobility & Transportation. | San Francisco, California |
 Eve | | |
 Eve.com | | |
 Even | Get paid early. OnePay @Work lets you access your earned wages before payday, track your earnings, and save automatically. All free through your employer. | India |
 Even | Even Healthcare is an Indian healthcare company offering members integrated primary care, diagnostics, specialist access and hospitalization coverage through subscription plans. | San Francisco, California |
 Even | | |
 Even | | |
| Even Healthcare | Even Healthcare is an Indian healthcare company offering members integrated primary care, diagnostics, specialist access and hospitalization coverage through subscription plans. | |
 Eventbrite | | |
 Eventifier | Eventifier operates in SaaS. | |
 Eventual | Enterprise Software company. | |
 Eventual | | |
 EvenUp | Generative AI for personal-injury demand letters. Founded 2019. San Francisco. | San Francisco, California |
 EvenUp | | |
 Ever | Consumer company. | |
 Ever Cars Co. | Mobility & Transportation company. | San Francisco, CA, US · Costa Mesa, CA, US |
 EVER Pharma | EVER Pharma is a privately owned specialty pharmaceutical group headquartered in Unterach, Austria, focused on neurology and complex sterile injectables for oncology, intensive care and hormone therapy. The group traces its origins to EBEWE Pharma, founded in Vienna in 1934; the neurology business was spun off and rebranded EVER Pharma in 2008–2009 when the oncology business was sold to Novartis. Its facilities in Austria and Germany develop and manufacture injectable medicines and drug-delivery devices. Its neurological product portfolio includes Cerebrolysin and Dacepton, alongside D-mine pen and infusion-pump devices for Parkinson’s disease medication delivery; indications and availability depend on the local market. Its published group management includes chairman and owner Friedrich Hillebrand, CEO Georges Kahwati, and managing director and co-owner Julia Hillebrand. The website identifies EVER Neuro Pharma GmbH and EVER Pharma Jena GmbH as operating entities. Although nyra health financing announcements use the EVER Pharma brand, its registered shareholder and historical investment vehicle is the separate Hillebrand family-office entity HIL-INVENT Ges.m.b.H.; those equity participations must not be attributed to the operating pharmaceutical group. Published R&D spending and manufacturing investments are operational expenditure rather than venture financing rounds. | Unterach, Austria · Jena, Germany |
 Everactive | Company operating in Hardware & Semiconductors. | |
 Everbright Health | Everbright Health is a US healthcare technology and services business, operated by Careforce Inc., that helps existing mental-health practices add and manage interventional psychiatry services. Its Activate AI platform supports review of clinical records, identification and outreach to potentially eligible patients, scheduling and payer prior-authorization workflows. The company also provides equipment, technical staffing, operational support, billing and compliance infrastructure for services such as transcranial magnetic stimulation (TMS) and SPRAVATO treatment. Its model embeds these service lines within partner practices, including treatment-resistant depression care, rather than manufacturing a drug or stimulation device. Founded by Ben Kuhn and Ginger Holguin and incubated by W Health Ventures/2070 Health, Everbright announced its launch and seed investment in October2025. Its current public leadership includes a psychiatrist serving as Chief Medical Officer. | |
 everdrop | Consumer company. | |
 Everestlabs | Company operating in Robotics & Automation. | |
 Evergrow | Climate & Energy company. | |
 Everlab | Everlab operates in Healthcare. | |
 Everlywell | Company operating in Healthcare. | |
 Evernest | Company operating in PropTech. | |
 Evernote Corporation | | |
 Evernow | Evernow operates in Healthcare. | |
 everspin | 16 years in the making, Everspin just unveiled the first spin-torque MRAM, a contender for a new generation of memory chip technology. Our original investment thesis for novel memory technologies (like Coatue/AMD, Nantero and Everspin) was a sense that Moore’s Law would begin to bifurcate, where technical advances in memory precede logic by several years. In the next few years, radical advances in memory density and performance will be needed to relieve the performance bottleneck in corporate computing. These new technologies are non-volatile rad-hard memories that should be faster, smaller, cooler, cheaper and more reliable than the SRAM and DRAM kludge. Background: Memory advances are becoming increasingly important to further advances in computing and computation. The mention of Moore’s | |
 Eversport | | |
 Eversports | Eversports is an all-in-one platform for studios to handle bookings, payments, and marketing, alongside a consumer app to find and book activities. Headquartered in Vienna, the company has grown since 2013 to power thousands of studios and millions of annual bookings across Europe. In 2024, Eversports was acquired in a majority buyout by Verdane. | 🇦🇹 · Austria |
 EverString | | |
 Evertune | Media & Entertainment company. | |
 Evervault | Fintech company. | |
 Every | | |
 EveryoneSocial | Enterprise Software company. | |
 Everyrealm | Metaverse, NFT, and virtual real estate company. Founded 2021. New York. | New York, New York |
 Evidencehunt | Uses AI to search and summarize medical research for healthcare professionals. | |
 Evident Battery | Company operating in Climate & Energy. | |
 Evify | Provides last-mile delivery services using electric vehicles in Indian cities. Its fleet and logistics technology support grocery, food, e-commerce and local deliveries, combining rider operations, vehicle management and route execution to help customers replace petrol-powered delivery fleets. | |
 Evity Technologies | Builds a clinical intelligence platform that helps healthcare organizations assess health risks and support preventative care and healthy aging. | |
 EvolutionaryScale | Company operating in Biotech & Life Sciences. | |
 EvolutionIQ | Insurance company. | |
 Evolv | Workforce analytics software that used machine learning and employee data to help large employers predict performance and improve hiring and retention; acquired by Cornerstone OnDemand. | |
 Evolv Technologies | Cybersecurity company. | |
 Evolv Technology | | |
 Evonetix | Evonetix operates in Biotech & Life Sciences. | |
 Evroc | Evroc operates in Infrastructure & Cloud. | |
 Evry Health | | |
 EVRYTHNG | EVRYTHNG operates in Data & Analytics. | |
 Evvy | Healthcare company. | |
 Ewake | Ewake develops AI agents for site reliability engineering and production incident response. Its software connects to observability tools, infrastructure and code to investigate alerts, identify root causes, triage incidents and recommend or prepare fixes. On-call, incident and background agents work across an engineering team’s production context, with changes proposed as scoped pull requests and automation controlled by the team’s permissions. The company operates from Paris. | |
 EX-IQ | Ex-IQ developed software that turned digital documents into interactive audiobooks. Its tools let learners listen to content, highlight passages and dictate notes through mobile and voice interfaces. | |
 Exa | AI research lab redesigning search for AI, with an API for knowledge retrieval. | San Francisco, California |
 Exabeam | Provides security analytics and threat detection software that helps organizations investigate suspicious activity and respond to cyberattacks. | |
 Exactly.ai | Company operating in AI. | |
 Exaforce | | |
 Exafunction | GPU cloud for AI development. | |
 Examedi | Healthcare company. | Santiago, Región Metropolitana, CL · Chile, CL |
 Excelsior Sciences | Company operating in Biotech & Life Sciences. | |
 Exciva | Exciva is a clinical-stage biotechnology company founded in 2016 in Heidelberg, Germany, developing therapies for neuropsychiatric symptoms of dementia and other brain disorders. Its investigational lead drug Deraphan combines dextromethorphan with deramciclane to address agitation in Alzheimer’s disease dementia. Following Phase1 development, it began the Phase2/3 SERENADA trial in April2026. The company was founded by Anton Bespalov, Hans Moebius and Sreenivasarao (Rao) Vepachedu; its current CEO is François Conquet. Its programs remain investigational, with efficacy being evaluated in clinical trials. | |
 exe.dev | exe.dev operates in Developer Tools. | |
 Exein | Exein develops AI-powered cybersecurity software that runs inside the firmware and operating systems of connected devices, robots and other physical AI systems. Its Runtime platform detects and contains threats on-device, while Analyzer checks firmware binaries and software bills of materials for vulnerabilities. The Rome-headquartered company serves manufacturers and operators in industrial IoT, energy, healthcare, automotive, semiconductors and critical infrastructure, and is developing machine-behavior foundation models for autonomous security. | |
 Exly | | |
 EXO Freight | EXO Freight operates a managed transportation marketplace focused on open-deck shipping, using software and a carrier network to match shippers with flatbed capacity and manage freight execution. | |
 Exo Imaging | Company operating in Healthcare. | |
 Exonar | Exonar operates in Cybersecurity. | |
 Exosonic | | |
 Exotanium | | |
 Exotec | Exotec operates in Robotics & Automation. | |
 Exoticca | Exoticca operates in Travel & Hospitality. | |
 Exowatt | Exowatt operates in Climate & Energy. | |
 Expedock | Company operating in Logistics & Supply Chain. | |
 Expensya | Company operating in Fintech. | |
 Experiment | | |
 Expert Intelligence | Company operating in Biotech & Life Sciences. | |
 Explo | Data & Analytics company. | |
 Explorex | E-Commerce & Marketplace company. | Bangalore, Karnataka, IN |
 Exponent Energy | Company operating in Mobility & Transportation. | |
 Exponent Energy Pvt | Indian energy-technology company building batteries, charging stations and software that enable 15-minute rapid charging for commercial electric vehicles. | |
 ExpressionEdits | Company operating in Biotech & Life Sciences. | |
 EXRobotics | Robotics & Automation company. | |
 Exsure | Develops exosome-based drug delivery technology intended to target cancer cells more precisely and reduce the toxicity of chemotherapy. | |
 Extend | Company operating in SaaS. | |
 Extend | | |
 Extensity | Enterprise workforce-optimization software company known for web-based travel and expense-management applications; acquired by Geac in 2003. | |
 Extropic | Climate & Energy company. | |
 Eye Security | Eye Security operates in Cybersecurity. | |
 Eye2Gene | Eye2Gene is a London precision-ophthalmology company combining retinal imaging, genomics and machine learning to identify likely genetic causes of inherited retinal disease. Its software prioritises candidate genes, measures imaging biomarkers and supports diagnosis, clinical-trial recruitment and gene-therapy development. The 2025 Nature Machine Intelligence study provides retrospective research validation; it does not establish universal clinical accuracy or regulatory approval. An active Innovate UK project aims to obtain UKCA/CE approval before clinical deployment.
The active legal entity is Eye2Gene Limited, UK company 11534583, incorporated on 23 August 2018. UCL Ventures and the issuer date its commercial spinout to 2026; that milestone is distinct from legal incorporation. Phenopolis Limited (11541164) is a separate software company sharing researchers, with no verified rename or merger. The technology originated in UCL Institute of Ophthalmology and Moorfields research.
Published leadership includes CEO/co-founder Nikolas Pontikos, CTO/co-founder Ismail Moghul, Chief AI Officer/co-founder William Woof and CMO/co-founder Michel Michaelides. Elis Yalman manages projects and medical-science liaison. The issuer's 2026 staff introductions also name Errolson Gonito, Alan Sousa da Silva, Judith McCarron, Saumya Agrawal, Oksana Krykun, commercial adviser Bruce Hellman and commercial intern Andrés Edwards. Saumya's October 2026 move from Founder Associate to part-time communications is qualified separately. Public profile-member counts and research coauthorship are not treated as undisclosed employees.
The corrected statutory share-allotment filing records cash shares issued during 23–30 March 2026: 328,945 A ordinary shares at GBP 3.04 and 80,000 ordinary shares at GBP 0.00001, totalling GBP 999,993.60. A separate 6–20 July 2026 allotment records 90,570 A ordinary shares at GBP 3.04, totalling GBP 275,332.80. These are statutory subscription periods, with series labels, individual buyers and exact closing days undisclosed. Exact cents remain in evidence because the structured Money field supports whole units. The original March SH01 was replaced on 3 August 2026.
Innovate UK's official project 10189359 records a GBP 298,345 grant offer to Eye2Gene Limited for regulatory approval, active May 2026–November 2027. GBP 662,989 is project cost, not the grant; an offer is not proof of bank disbursement. Twin Path Ventures' exact-domain portfolio confirms an undated investment affiliation without allocating it to either statutory allotment. Earlier NIHR and charity awards supported academic research and are not automatically company cash. Support logos alone do not establish paid equity checks by KQ Labs, UCLB, AWS, Adeline or Cambridge Angels. Secondary claims of a November 2025 USD 921,000 seed and USD 2.73 million cumulative financing remain unverified. | London, United Kingdom |
 Eyeball Games | Company operating in Gaming. | |
 Eyebiotech Limited | Clinical-stage biotechnology company developing therapies for retinal and other sight-threatening eye diseases; acquired by Merck in 2024. | |
 Eyebot | Healthcare company. | |
 Eyebot | | |
 EyeEm | Media & Entertainment company. | |
 Eyenuk | Eyenuk develops retinal-image analysis software that brings AI screening and eye-care coordination into primary care, diabetes clinics and ophthalmic practices. Its EyeArt system analyzes photographs of the retina to autonomously detect more-than-mild and vision-threatening diabetic retinopathy and return a diagnostic report without a specialist reading every exam. EyeArt has FDA 510(k) clearance for diabetic-retinopathy detection in the United States; the company also reports EU MDR Class IIb certification for detecting diabetic retinopathy, age-related macular degeneration and glaucomatous optic-nerve damage. Its EyeScreen workflow supports expert human review of inconclusive images and non-DR findings, prioritized referrals and integration with electronic health records. A longitudinal monitoring workspace lets clinicians compare retinal findings and follow disease progression. Eyenuk also researches retinal biomarkers for systemic cardiovascular and neurological health; these research ambitions do not establish regulatory clearance for diagnosing Alzheimer’s disease or other neurological conditions. Founded in 2010, the company operates from the Los Angeles area and publishes a San Francisco correspondence address. | Los Angeles, California, United States |
 Eyeota | Company operating in Data & Analytics. | |
 EyeROV | Develops underwater robots and autonomous marine vehicles for inspection, surveying and other work in marine environments. | |
 Eyeview | | |
 eyva | AI company. | |
 ezCater | Company operating in Food & Agriculture. | |
 EzDubs | | |
 EZE | | |
 EZE Wholesale | | |
 Ezra | Healthcare company. | |
 F2 | | |
 Fabentech | Biotech & Life Sciences company. | |
 FabFitFun | Company operating in E-Commerce & Marketplace. | |
 Fable Food | Australian food-technology company making minimally processed, mushroom-based meat alternatives for retail and foodservice. | |
 Fable Therapeutics | Biotech & Life Sciences company. | |
 Fabric | Fabric operates in E-Commerce & Marketplace. | |
 Fabric Health | | |
 Fabric8 | Company operating in Manufacturing. | |
 Fabricly | Fabricly operates in E-Commerce & Marketplace. | |
 FabricNano | Cell-free biomanufacturing using enzymes on natural materials to replace petrochemical products. Founded 2018 by Grant Aarons and Ferdinando Randisi. | London, United Kingdom |
 Facebook | Facebook operates in Social & Community. | |
 Facet | Facet operates in Marketing & Advertising. | |
 FaceUp | SaaS company. | |
 Facilio | Facilio operates in PropTech. | |
 Facio | | |